卧虎藏龙 Crouching Tiger Hidden Dragon [BEST Fight Scene]



Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter

  • Biotech unicorn Moderna Therapeutics, which is valued at more than .5 billion, may file for an initial public offering as early as this winter, according to STAT news.
  • The company has reportedly hired banks including Goldman Sachs, JPMorgan, and Morgan Stanley to help it with its debut on Wall Street.
  • Moderna develops mRNA-based therapeutics and vaccines, 10 of which are currently in the clinical pipeline.
  • It has disclosed strategic relationships with AstraZeneca, Merck, and Vertex Pharmaceuticals.

Moderna Therapeutics may file for an initial public offering as early as this winter, STAT news reported earlier this week.

The Cambridge-based was founded in 2010 and now has a valuation of more than .5 billion. Additionally, Moderna has reportedly hired banks including Goldman Sachs, JPMorgan, and Morgan Stanley to help it gear up for its stock debut.

Moderna Therapeutics declined to comment on the report.

Moderna develops messenger RNA (mRNA) therapeutics and vaccines, which hijacks the body's cells to produce proteins that can combat cancer, infectious disease, rare diseases, and cardiovascular diseases. These types of therapeutics can present certain complications. Researchers have to avoid immune reactions, target specific cells, safely transfer mRNA into cells, and ensure that enough protein is being made.

Over the past five years, Moderna has spent 0 million on research into mRNA medicines and plans to spend another 0 million over the next five years, according to the American Chemical Society.

According to a recent press release, Moderna has 21 mRNA-based candidates in its pipeline. Of those, 10 are in clinical development including 9 infectious disease vaccine programs and 7 candidates in Phase 1 trials.

Last week, the company announced that Dr. Wellington Sun will join the company as its head of Vaccine Strategy and Regulatory Affairs, starting later in September. Sun previously held a position at the FDA as the Director of the Division of Vaccines and Related Product Applications at the Center for Biologics Evaluation and Research.

Moderna is currently engaged in strategic relationships with AstraZeneca, Merck, and Vertex Pharmaceuticals. It has also disclosed connections to the Defense Advanced Research Projects Agency of the U.S. Department of Defense, the Biomedical Advanced Research and Development Authority of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, and the Bill & Melinda Gates Foundation.






Video: Le Donne Guardano in Mezzo alle Gambe degli Uomini in Spiaggia? - [Esperimento Sociale] - theShow

Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter
Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter images

2019 year
2019 year - Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter pictures

Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter forecasting
Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter recommendations photo

Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter pics
Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter images

Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter new pictures
Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter new photo

pictures Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter
pics Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter

Watch Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter video
Watch Biotech Unicorn Moderna Therapeutics could be gearing up for an IPO as early as this winter video

Forum on this topic: Biotech Unicorn Moderna Therapeutics could be gearing , biotech-unicorn-moderna-therapeutics-could-be-gearing/
Discussion on this topic: Biotech Unicorn Moderna Therapeutics could be gearing , biotech-unicorn-moderna-therapeutics-could-be-gearing/ , biotech-unicorn-moderna-therapeutics-could-be-gearing/

Related News


Orange Chiffon Cake with Buttermilk Ice Cream
AirDates Is The New App Thats Tinder For The Skies
How to Date Old Ball Mason Jars
Tula Karras
Sarkozy marries Carla Bruni
Beauty Recipe: Golden EyeMakeup
The Men’s Health Fittest Football XI
Jeremy Laing to IVANAhelsinki: Our Final NYFW Diary With StyleCaster’s EditorialManager
How to Protect Aluminium
Do Not Attempt These Insane Braids Without AProfessional
Best fashionable looks from MTV Video Music Awards 2014
Cute Tops to Wear with Jeans – 21 Jeans Tops Outfit Ideas
If Youve Ever Said I Just Dont Feel Right, You Need To Read This About Silent Heart Attacks



Date: 15.12.2018, 17:08 / Views: 93341